Investing.com - The International Monetary Fund warned Monday that the US-Israeli war against Iran threatens a "global, yet asymmetric" shock, dimming the outlook for economies recovering from ...
Federal Reserve Chair Jerome Powell on Monday said monetary policy was in a good place to “wait and see” the effects of surging oil prices due to the ongoing Middle East conflict on U.S. inflation and ...
A Starlink satellite experienced an anomaly on Sunday, resulting in loss of communications with the spacecraft at approximately 560 kilometers above Earth, the company said on X Monday. Starlink ...
The Texas joint venture between QatarEnergy and Exxon Mobil Corp. has started liquefied natural gas production from the first of its three trains at the facility, ...
A Delaware judge said Monday she will no longer oversee several lawsuits involving Elon Musk and his companies after the billionaire’s attorneys claimed she sho ...
South Korean AI chip startup Rebellions raised $400 million on Monday at a valuation of $2.34 billion as the company prepares to expand into the U.S. market ahead ...
Global air cargo demand increased 11.2% in February 2026 compared to the same month in 2025, according to data released Monday by the International Air Transport ...
YY Group Holding Ltd (NASDAQ:YYGH) shares rose 4.4% Monday after the company announced it would pause its At-The-Market equity offering program and cancel over 1 million unissued shares. The on-demand ...
Kezar Life Sciences Inc. (NASDAQ:KZR) shares rose 19.2% Monday following Aurinia Pharmaceuticals Inc.’s (NASDAQ:AUPH) announcement to acquire the company for $6.955 in cash per share plus a contingent ...
Avis Budget Group Inc (NASDAQ:CAR) shares fell 3.3% Monday after the company announced an at-the-market equity offering program. The car rental company entered into an Equity Distribution Agreement on ...
Common shares of mortgage finance giants Fannie Mae and Freddie Mac jumped more than 30% in trading on Monday. Over the weekend, investor Bill Ackman said in a po ...
Raymond James lowered its rating on Boston Scientific to Outperform from Strong Buy in a note to clients on Monday, citing increased variability in the company’s key growth drivers despite maintaining ...